Toyos Clinic   Report issue

Academic/Hospital Phase 4
Founded: Jackson TN United States (1998)

Organization Overview

First Clinical Trial
2013
NCT01847638
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Melissa Toyos, MD | Toyos Clinic | Toyos Clinic (Nashville, TN, USA)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Conjunctivitis (Phase 4)

Conjunctivitis, Allergic (Phase 4)

Dry Eye Syndromes (Phase 4)

Eye Diseases (Phase 4)

Hypersensitivity (Phase 4)

Keratoconjunctivitis Sicca (Phase 4)

Signs and Symptoms (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial APIs: 6